Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity

Bibliography

• Ehrlich P. Die Seitenkettentheorie und ihre Gegner. Muenchener medizinische Wochenschrift 1901;52:2123-4
   Google Scholar
• Cohen BE, Bangham AD. Diffusion of small nonelectrolytes across liposome membranes. Nature 1972;236:173-4
   PubMed Web of Science ®Google Scholar
• Devine DV, Bradley AJ. The complement system in liposome clearance: can complement deposition be inhibited? Adv Drug Deliv Rev 1998;32:19-29
   PubMed Web of Science ®Google Scholar
• Devine DV, Wong K, Serrano K, Liposome-complement interactions in rat serum- implications for liposome survival studies. Biochim Biophys Acta 1994;1191:43-51
   PubMed Web of Science ®Google Scholar
• Ishida T, Harashima H, Kiwada H. Liposome clearance. Biosci Rep 2002;22:197-224
   PubMed Web of Science ®Google Scholar
• Liu DX. Biological factors involved in blood clearance of liposomes by liver. Adv Drug Deliv Rev 1997;24:201-13
   Web of Science ®Google Scholar
• Liu F, Liu DX. Amphipathic polyethylene glycol stabilized emulsions (o/w): Physical characterization and in vivo distribution. Int J Pharm 1995;125:73-80
   Web of Science ®Google Scholar
• Liu F, Liu DX. Serum independent liposome uptake by mouse liver. Biochim Biophys Acta 1996;1278:5-11
   PubMed Web of Science ®Google Scholar
• Liu SC, Ishida T, Kiwada H. Effect of serum components from different species on destabilizing hydrogenated phosphatidylcholine-based liposomes. Biol Pharm Bull 1997;20:874-80
   PubMed Web of Science ®Google Scholar
• Oja CD, Semple SC, Chonn A, Influence of dose on liposome clearance: critical role of blood proteins. Biochim Biophys Acta 1996;1281:31-7
   PubMed Web of Science ®Google Scholar
• Senior J, Crawley JCW, Gregoriadis G. Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous-injection. Biochim Biophys Acta 1985;839:1-8
   PubMed Web of Science ®Google Scholar
• Hope MJ, Bally MB, Mayer LD, Generation of multilamellar and unilamellar phospholipid vesicles. Chem Phys Lipids 1986;40:89-107
   Web of Science ®Google Scholar
• Mayer LD, Hope MJ, Cullis PR. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 1986;858:161-8
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D, Allen TM, Gabizon A, Sterically stabilized liposomes - improvements in pharmacokinetics and antitumor therapeutic efficacy. PNAS 1991;88:11460-4
   PubMed Web of Science ®Google Scholar
• Pashin YV, Bakhitova LM, Bentkhen TI. Antimutagenic activity of simple phenols and its dependence on the number of hydroxyl groups. Bull Exp Biol Med 1986;102:1121-3
   Web of Science ®Google Scholar
• Woodle MC, Lasic DD. Sterically stabilized liposomes. Biochim Biophys Acta 1992;1113:171-99
   PubMed Web of Science ®Google Scholar
• Woodle MC, Newman MS, Cohen JA. Sterically stabilized liposomes: physical and biological properties. J Drug Target 1994;2:397-403
   PubMed Web of Science ®Google Scholar
• Woodle MC, Newman MS, Collins LR, Efficient evaluation of long circulating or stealth liposomes by studies of invivo blood-circulation kinetics and final organ distribution in rats. Biophys J 1990;57:A261
   Google Scholar
• Allen TM, Hansen C, Martin F, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991;1066:29-36
   PubMed Web of Science ®Google Scholar
• Drummond DC, Meyer O, Hong KL, Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999;51:691-743
   PubMed Web of Science ®Google Scholar
• Proffitt RT, Williams LE, Presant CA, Tumor-imaging potential of liposomes loaded with in-111-nta - biodistribution in mice. J Nucl Med 1983;24:45-51
   PubMed Web of Science ®Google Scholar
• Yuan F, Leuning M, Huang SK, Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res 1994;54:3352-6
   PubMed Web of Science ®Google Scholar
• Loi M, Marchio S, Becherini P, Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma. J Control Release 2010;145:66-73
   PubMed Web of Science ®Google Scholar
• Pastorino F, Di Paolo D, Loi M, Recent advances in targeted anti-vasculature therapy: the neuroblastoma model. Curr Drug Targets 2009;10:1021-7
   PubMed Web of Science ®Google Scholar
• Pastorino F, Marimpietri D, Brignole C, Ligand-targeted liposomal therapies of neuroblastoma. Curr Med Chem 2007;14:3070-8
   PubMed Web of Science ®Google Scholar
• Sapra P, Allen TM. Ligand-targeted liposomal anticancer drugs. Progress Lip Res 2003;42:439-62
   PubMed Web of Science ®Google Scholar
• Barenholz Y, Amselem S, Goren D, Stability of liposomal doxorubicin formulations - problems and prospects. Med Res Rev 1993;13:449-91
   PubMed Web of Science ®Google Scholar
• Barenholz Y, Bolotin E, Cohen R, Sterically stabilized doxorubicin loaded liposomes (DOX-SL(TM)): from basics to the clinics. Phosphorus Sulfur Silicon Relat Elem 1996;109:293-6
   Web of Science ®Google Scholar
• Emanuel N, Kedar E, Bolotin EM, Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomes. Pharm Res 1996;13:352-9
   PubMed Web of Science ®Google Scholar
• Gabizon A, Catane R, Uziely B, Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994;54:987-92
   PubMed Web of Science ®Google Scholar
• Gabizon A, Isacson R, Libson E, Clinical-studies of liposome-encapsulated doxorubicin. Acta Oncol 1994;33:779-86
   PubMed Web of Science ®Google Scholar
• Cullis PR, Hope MJ, Bally MB, Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim Biophys Acta 1997;1331:187-211
   PubMed Web of Science ®Google Scholar
• Lasic DD. Liposomes: from physics to aplications. Elsevier Science B.V., Amsterdam; 1993
   Google Scholar
• Lasic DD. The mechanism of vesicle formation. Biochem J 1988;256:1-11
   PubMed Web of Science ®Google Scholar
• Szoka FC. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng 1980;9:467-508
   PubMedGoogle Scholar
• Lichtenberg D, Barenholz Y. Liposomes - preparation, characterization, and preservation. Methods Biochem Anal 1988;33:337-462
   PubMedGoogle Scholar
• Woodle MC, Papahadjopoulos D. Liposome preparation and size characterization. 1997. Academic Press, INC, San Diego; 1997
   Google Scholar
• Mayer LD, Hope MJ, Cullis PR, Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta 1985;817:193-6
   PubMed Web of Science ®Google Scholar
• Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 1973;298:1015-19
   PubMed Web of Science ®Google Scholar
• Wagner A, Platzgummer M, Kreismayr G, GMP production of liposomes - A new industrial approach. J Liposome Res 2006;16:311-19
   PubMed Web of Science ®Google Scholar
• Szoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. PNAS 1978;75:4194-8
   PubMed Web of Science ®Google Scholar
• Embree L, Gelmon KA, Lohr A, Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung-cancer patients. J Pharm Sci 1993;82:627-34
   PubMed Web of Science ®Google Scholar
• Frezard F, Garnier-Suillerot A. Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature. Biochim Biophys Acta 1998;1389:13-22
   PubMed Web of Science ®Google Scholar
• Gregoriadis G, Panagiotidi C. Immunoadjuvant action of liposomes: comparison with other adjuvants. Immunol Lett 1989;20:237-40
   PubMed Web of Science ®Google Scholar
• Gallois L, Fiallo M,Garnier Suillerot A. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles - Circular dichroism study. Biochim Biophys Acta 1998;1370:31-40
   PubMed Web of Science ®Google Scholar
• Harrigan PR, Wong KF, Redelmeier TE, Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim Biophys Acta 1993;1149:329-38
   PubMed Web of Science ®Google Scholar
• Madden TD, Harrigan PR, Tai LCL, The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient - a survey. Chem Phys Lipids 1990;53:37-46
   PubMed Web of Science ®Google Scholar
• Regev R, Yeheskely-Hayon D, Katzir H, Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanism. Biochem Pharmacol 2005;70:161-9
   PubMed Web of Science ®Google Scholar
• Chakrabarti AC, Clarklewis I, Harrigan PR, Uptake of basic-amino-acids and peptides into liposomes in response to transmembrane pH gradients. Biophys J 1992;61:228-34
   PubMed Web of Science ®Google Scholar
• Bally MB, Mayer LD, Loughrey H, Dopamine accumulation in large unilamellar vesicle systems induced by transmembrane ion gradients. Chem Phys Lipids 1988;47:97-107
   PubMed Web of Science ®Google Scholar
• Mayer LD, Bally MB,Cullis PR. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta 1986;857:123-6
   PubMed Web of Science ®Google Scholar
• Mayer LD, Bally MB, Hope MJ, Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane-potential. Biochim Biophys Acta 1985;816:294-302
   PubMed Web of Science ®Google Scholar
• Chou TH, Chen SC,Chu IM. Effect of composition on the stability of liposomal irinotecan prepared by a pH gradient method. J Biosci Bioeng 2003;95:405-8
   PubMed Web of Science ®Google Scholar
• Dos Santos N, Cox KA, McKenzie CA, pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol. Biochim Biophys Acta 2004;1661:47-60
   PubMed Web of Science ®Google Scholar
• Dos Santos N, Waterhouse D, Masin D, Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity. J Control Release 2005;105:89-105
   PubMed Web of Science ®Google Scholar
• Forssen EA. The design and development of DaunoXome(R) for solid tumor targeting in vivo. Adv Drug Deliv Rev 1997;24:133-50
   Web of Science ®Google Scholar
• Swenson CE, Perkins WR, Roberts P, Liposome technology and the development of Myocet (TM) (liposomal doxorubicin citrate). Breast 2001;10:1-7
   PubMed Web of Science ®Google Scholar
• Dos Santos N, Mayer LD, Abraham SA, Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes. Biochim Biophys Acta 2002;1561:188-201
   PubMed Web of Science ®Google Scholar
• Li XG, Hirsh DJ, Cabral-Lilly D, Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. Biochim Biophys Acta 1998;1415:23-40
   PubMed Web of Science ®Google Scholar
• Haran G, Cohen R, Bar LK, Transmembrane ammonium-sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta 1993;1151:201-15
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci 2001;6:66-77
   Web of Science ®Google Scholar
• Fritze A, Hens F, Kimpfler A, Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim Biophys Acta 2006;1758:1633-40
   PubMed Web of Science ®Google Scholar
• Seynhaeve ALB, Hoving S, Schipper D, Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response. Cancer Res 2007;67:9455-62
   PubMed Web of Science ®Google Scholar
• Laginha KM, Verwoert S, Charrois GJR, Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res 2005;11:6944-9
   PubMed Web of Science ®Google Scholar
• Lindner LH, Hossann M. Factors affecting drug release from liposomes. Curr Opin Drug Discovery Dev 2010;13:111-23
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006;58:1532-55
   PubMed Web of Science ®Google Scholar
• Gubernator J, Chwastek G, Korycinska M, The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo. J Control Release 2010;146:68-75
   PubMed Web of Science ®Google Scholar
• Lasic DD, Ceh B, Stuart MCA, Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. Biochim Biophys Acta 1995;1239:145-56
   PubMed Web of Science ®Google Scholar
• Maurer N, Wong KF, Hope MJ, Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a H-1-NMR study. Biochim Biophys Acta 1998;1374:9-20
   PubMed Web of Science ®Google Scholar
• Zucker D, Marcus D, Barenholz Y, Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties. J Control Release 2009;139:73-80
   PubMed Web of Science ®Google Scholar
• Clerc S, Barenholz Y. Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. Biochim Biophys Acta 1995;1240:257-65
   PubMed Web of Science ®Google Scholar
• Deamer DW, Crofts AR, Prince RC. Response of fluorescent amines to ph gradients across liposome membranes. Biochim Biophys Acta 1972;274:323-35
   PubMed Web of Science ®Google Scholar
• Fenske DB, Wong KF, Maurer E, Ionophore-mediated uptake of ciprofloxacin and vincristine into large unilamellar vesicles exhibiting transmembrane ion gradients. Biochim Biophys Acta 1998;1414:188-204
   PubMed Web of Science ®Google Scholar
• Erdahl WL, Chapman CJ, Taylor RW, Ca2+ transport-properties of ionophores a23187, ionomycin, and 4-bra23187 in a well-defined model system. Biophys J 1994;66:1678-93
   PubMed Web of Science ®Google Scholar
• Erdahl WL, Chapman CJ, Taylor RW, Effects of pH conditions on Ca2+ transport catalyzed by ionophores A23187, 4-BrA23187, and ionomycin suggest problems with common applications of these compounds in biological systems. Biophys J 1995;69:2350-63
   PubMed Web of Science ®Google Scholar
• Pressman BC. Biological applications of ionophores. Ann Rev Biochem 1976;45:501-30
   PubMed Web of Science ®Google Scholar
• Johnston MJW, Semple SC, Klimuk SK, Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochim Biophys Acta 2006;1758:55-64
   PubMed Web of Science ®Google Scholar
• Cheung BCL, Sun THT, Leenhouts JM, Loading of doxorubicin into liposomes by forming Mn2+-drug complexes. Biochim Biophys Acta 1998;1414:205-16
   PubMed Web of Science ®Google Scholar
• Cui J, Li CL, Wang LF, Ni2+-mediated mitoxantrone encapsulation: Improved efficacy of fast release formulation. Int J Pharm 2009;368:24-30
   PubMed Web of Science ®Google Scholar
• Li CL, Cui JX, Li YG, Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release. Eur J Pharm Sci 2008;34:333-44
   PubMed Web of Science ®Google Scholar
• Abraham SA, McKenzie C, Masin D, In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading. Clin Cancer Res 2004;10:728-38
   PubMed Web of Science ®Google Scholar
• Ramsay E, Alnajim J, Anantha M, A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention. Eur J Pharm Biopharm 2008;68:607-17
   PubMed Web of Science ®Google Scholar
• Taggar AS, Alnajim J, Anantha M, Copper-topotecan complexation mediates drug accumulation into liposomes. J Control Release 2006;114:78-88
   PubMed Web of Science ®Google Scholar
• Tardi PG, Gallagher RC, Johnstone S, Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo. Biochim Biophys Acta 2007;1768:678-87
   PubMed Web of Science ®Google Scholar
• Boman NL, Bally MB, Cullis PR, Encapsulation of vincristine in liposomes reduces its toxicity and improves its anti-tumor efficacy. J Liposome Res 1995;5:523-41
   Google Scholar
• Boman NL, Masin D, Mayer LD, Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing p388 tumors. Cancer Res 1994;54:2830-3
   PubMed Web of Science ®Google Scholar
• Charrois GJR, Allen TM. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim Biophys Acta 2004;1663:167-77
   PubMed Web of Science ®Google Scholar
• Zhigaltsev IV, Maurer N, Edwards K, Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention. J Control Release 2006;110:378-86
   PubMed Web of Science ®Google Scholar
• Abraham SA, Edwards K, Karlsson G, An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes. J Control Release 2004;96:449-61
   PubMed Web of Science ®Google Scholar
• Zhigaltsev IV, Winters G, Srinivasulu M, Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles. J Control Release 2010;144:332-40
   PubMed Web of Science ®Google Scholar
• Webb MS, Boman NL, Wiseman DJ, Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation. Antimicrob Agents Chemother 1998;42:45-52
   PubMed Web of Science ®Google Scholar
• Boccardo F, Cannata D, Cussotto M, Intravesical idarubicin: a dose finding study. Cancer Chemother Pharmacol 1996;38:102-5
   PubMed Web of Science ®Google Scholar
• Hossann M, Wang TT, Wiggenhorn M, Size of thermosensitive liposomes influences content release. J Control Release 2010;147:436-43
   PubMed Web of Science ®Google Scholar
• Mayer LD, Nayar R, Thies RL, Identification of vesicle properties that enhance the antitumor-activity of liposomal vincristine against murine l1210 leukemia. Cancer Chemother Pharmacol 1993;33:17-24
   PubMed Web of Science ®Google Scholar
• Zhigaltsev IV, Maurer N, Akhong QF, Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. J Control Release 2005;104:103-11
   PubMed Web of Science ®Google Scholar
• Noble CO, Guo ZX, Hayes ME, Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine. Cancer Chemother Pharmacol 2009;64:741-51
   PubMed Web of Science ®Google Scholar
• Hennenfent KL,Govindan R. Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol 2006;17:735-49
   PubMed Web of Science ®Google Scholar
• Crosasso P, Ceruti M, Brusa P, Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 2000;63:19-30
   PubMed Web of Science ®Google Scholar
• Balasubramanian SV, Straubinger RM. Taxol-lipid interactions - taxol-dependent effects on the physical-properties of model membranes. Biochem 1994;33:8941-7
   PubMed Web of Science ®Google Scholar
• Mayer LD, Harasym TO, Tardi PG, Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice. Mol Cancer Ther 2006;5:1854-63
   PubMed Web of Science ®Google Scholar
• Mayer LD, Janoff AS. Optimizing combination chemotherapy by controlling drug ratios. Mol Interv 2007;7:216-23
   PubMed Web of Science ®Google Scholar
• Woo J, Chiu GNC, Karlsson G, Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermo sensitive liposomes. Int J Pharm 2008;349:38-46
   PubMedGoogle Scholar
• Wheeler JJ, Veiro JA,Cullis PR. Ionophore-mediated loading of ca2+ into large unilamellar vesicles in response to transmembrane ph gradients. Mol Membr Biol 1994;11:151-7
   PubMed Web of Science ®Google Scholar